Active Ingredient History
dl-α-tocopheryl phosphate has a growth acceleration effect on domestic fowl. Also was confirmed, that in all investigated animals dl-α-tocopheryl phosphate has an ability to being converted into vitamin E. NCATS
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Coronary Syndrome (Phase 3)
Acute Kidney Injury (Phase 2)
Adrenoleukodystrophy (Phase 2)
Aging (Phase 1)
Alzheimer Disease (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 3)
Anemia (Phase 2)
Anemia, Iron-Deficiency (Phase 1)
Anemia, Sickle Cell (Phase 4)
Angina Pectoris (Phase 4)
Angina, Stable (Phase 3)
Angina, Unstable (Phase 3)
Antioxidants (Phase 4)
Arterial Occlusive Diseases (Phase 3)
Asthenozoospermia (Phase 2/Phase 3)
Asthma (Phase 2)
Atherosclerosis (Phase 2/Phase 3)
Bites and Stings (Phase 3)
Brain Injuries (Phase 2)
Breast Neoplasms (Phase 3)
Burning Mouth Syndrome (Early Phase 1)
Burns (Phase 2/Phase 3)
Cardiovascular Diseases (Phase 3)
Carotid Artery Diseases (Phase 2)
Cataract (Phase 3)
Catheters (Phase 3)
Central Serous Chorioretinopathy (Phase 2)
Cerebrovascular Disorders (Phase 3)
Cicatrix (Early Phase 1)
Cicatrix, Hypertrophic (Phase 4)
Cognition Disorders (Phase 3)
Colitis, Ulcerative (Phase 2)
Colorectal Neoplasms (Phase 3)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Critical Illness (Phase 3)
Crohn Disease (Phase 2)
Cystic Fibrosis (Phase 2)
Delirium (Phase 3)
Depression (Phase 3)
Dermatology (Phase 1)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Foot (Phase 3)
Diabetic Retinopathy (Phase 3)
Down Syndrome (Phase 3)
Dry Eye Syndromes (Phase 4)
Dyslipidemias (Phase 4)
Dysmenorrhea (Phase 3)
Eclampsia (Phase 3)
Endometriosis (Phase 2)
End Stage Liver Disease (Early Phase 1)
Epilepsy (Phase 4)
Erectile Dysfunction (Phase 2)
Esophageal Mucosa (Phase 1)
Exercise Tolerance (Phase 2/Phase 3)
Fatty Liver (Phase 4)
Fibrosis (Phase 3)
Fragile X Syndrome (Phase 3)
Friedreich Ataxia (Phase 2)
General Surgery (Phase 1)
Glaucoma (Phase 3)
Graves Ophthalmopathy (Phase 2/Phase 3)
Head and Neck Neoplasms (Phase 3)
Healthy Volunteers (Phase 1)
Hearing Loss, Noise-Induced (Phase 2)
Heart Diseases (Phase 3)
Heart Failure (Phase 1)
Helicobacter pylori (Phase 4)
HELLP Syndrome (Phase 3)
Hemorrhage (Phase 3)
Hepatitis B, Chronic (Phase 4)
Hepatitis C, Chronic (Phase 3)
HIV Infections (Phase 2)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 1)
Hypertrophy, Left Ventricular (Phase 4)
Hypobetalipoproteinemias (Phase 3)
Infant, Newborn (Phase 1)
Infant, Premature (Phase 3)
Infant, Small for Gestational Age (Phase 1)
Infant, Very Low Birth Weight (Phase 1)
Infertility, Female (Early Phase 1)
Infertility, Male (Phase 4)
Inflammation (Phase 2/Phase 3)
Influenza A Virus, H1N1 Subtype (Phase 4)
Insulin (Phase 2)
Insulin Resistance (Phase 2/Phase 3)
Intracranial Arteriosclerosis (Phase 2)
Intracranial Hemorrhages (Phase 1)
Iron Deficiencies (Phase 1)
Keloid (Phase 4)
Kidney Calculi (Phase 4)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 1/Phase 2)
Lichen Planus, Oral (Phase 1)
Live Birth (Phase 4)
Liver Cirrhosis (Phase 3)
Liver Diseases (Phase 3)
Lung Diseases (Phase 3)
Lung Diseases, Obstructive (Phase 3)
Lung Neoplasms (Phase 3)
Lymphedema (Phase 2)
Macular Degeneration (Phase 3)
Macular Edema (Phase 1)
Malaria (Phase 3)
Meniere Disease (Phase 4)
Metabolic Syndrome (Phase 3)
Migraine Disorders (Phase 3)
Multiple Sclerosis (Phase 1/Phase 2)
Mycobacterium tuberculosis (Phase 3)
Myelodysplastic Syndromes (Phase 1/Phase 2)
Myeloproliferative Disorders (Phase 2)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 3)
Neuromuscular Diseases (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 4)
Obesity (Phase 3)
Obesity, Morbid (Early Phase 1)
Osteonecrosis (Phase 3)
Osteoradionecrosis (Phase 4)
Ovarian Neoplasms (Phase 1/Phase 2)
Oxidative Stress (Phase 4)
Pain (Phase 3)
Pain, Postoperative (Phase 3)
Pancreatic Neoplasms (Phase 1)
Pancreatitis (Phase 2/Phase 3)
Parenteral Nutrition (Phase 4)
Parkinson Disease (Phase 3)
Pediatric Obesity (Phase 4)
Penile Induration (Phase 1)
Peripheral Nervous System Diseases (Phase 2)
Poisoning (Phase 2)
Polycystic Ovary Syndrome (Phase 2)
Postmenopause (Phase 3)
Precancerous Conditions (Phase 3)
Pre-Eclampsia (Phase 3)
Pregnancy (Phase 3)
Prostatic Neoplasms (Phase 3)
Psychotic Disorders (Phase 2/Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 2/Phase 3)
Radiation Oncology (Phase 3)
Renal Dialysis (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Reperfusion Injury (Phase 2)
Restless Legs Syndrome (Phase 2/Phase 3)
Retinitis Pigmentosa (Phase 3)
Schizophrenia (Phase 3)
Semen Analysis (Phase 4)
Shock, Septic (Phase 3)
Short Bowel Syndrome (Phase 2)
Skin Care (Early Phase 1)
Sleep Apnea Syndromes (Early Phase 1)
Smoking (Phase 2)
Steatitis (Phase 4)
Stomatitis (Phase 2)
Subarachnoid Hemorrhage (Phase 3)
Surgical Wound Infection (Phase 3)
Thoracic Surgery (Phase 3)
Thrombocytopenia (Phase 1/Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Uveitis (Phase 1)
Vascular Diseases (Phase 3)
Vertigo (Phase 4)
Vitamin E Deficiency (Phase 2)
Work (Phase 3)
Wounds and Injuries (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
